Volunteer Assignments and Opportunities: Difference between revisions

[unchecked revision][unchecked revision]
No edit summary
No edit summary
Line 384: Line 384:
|Complete
|Complete
| ||JH / MS
| ||JH / MS
|02/03/2021-MS
|03/02/2021-MS
|Need to delete error message text in Categories section- MS 3/1/21
|
|-
|-
|    Myeloid Neoplasms with Germline ETV6  Mutation||Disease||Ying Zou
|    Myeloid Neoplasms with Germline ETV6  Mutation||Disease||Ying Zou
Line 392: Line 392:
|Complete
|Complete
| ||JH / MS
| ||JH / MS
|02/01/2021-MS (re-review)
|03/02/2021-MS (re-review)
|Need to delete error message text in Categories section- MS 3/1/21
|
|-
|-
|    Myeloid Neoplasms with Germline GATA2  Mutation||Disease||Daynna Wolff+ Alexandria Avery (Path Resident)
|    Myeloid Neoplasms with Germline GATA2  Mutation||Disease||Daynna Wolff+ Alexandria Avery (Path Resident)
Line 418: Line 418:
| ||JH / MS
| ||JH / MS
|
|
|Need author email contact to clarify 2 references - MS 02/17/21
|Contacted author to clarify 2 references - MS 03/02/21
|-
|-
|    Acute Myeloid Leukemia with  inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11||Disease||Christine Bryke
|    Acute Myeloid Leukemia with  inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11||Disease||Christine Bryke